PropertyValue
is ?:annotates of
?:authorAffiliation
  • [\'Division of Hematology and Oncology, Columbia University Irving Medical Center, and New York Presbyterian Hospital, Herbert Irving Pavilion, New York, NY.\', \'Division of Pathology and Cell Biology, Columbia University Irving Medical Center, and New York Presbyterian Hospital, New York, NY.\', \'Division of Biostatistics, Columbia University Mailman School of Public Health, New York, NY.\', \'Division of Hematology and Oncology, Columbia University Irving Medical Center, and New York Presbyterian Hospital, Herbert Irving Pavilion, New York, NY. Electronic address: gam2140@cumc.columbia.edu.\']
?:citedBy
  • -1
?:creator
?:doi
?:doi
  • S0093-7754(20)30121-410.1053/j.seminoncol.2020.11.001
?:hasPublicationType
?:journal
  • Seminars in oncology
is ?:pmid of
?:pmid
?:pmid
  • 33334607
?:publication_isRelatedTo_Disease
?:rankingScore_SJR
  • 2.099
?:rankingScore_hIndex
  • 121
is ?:relation_isRelatedTo_publication of
?:title
  • A double-edged sword: Prolonged detection of SARS-COV-2 in patients receiving cancer directed therapy.
?:type
?:year
  • 2021

Metadata

Anon_0  
expand all